Rishi Singh

Academic / Other · 3 registered clinical trials.

Status	Trial	Phase	Started
Completed	Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevaci Diabetic Retinopathy, Macular Edema	Phase 4	2015-10-01
Completed	Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery Diabetic Retinopathy	Phase 1 / Phase 2	2013-12-01
Completed	Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept Exudative Macular Degeneration	Phase 4	2012-06-01